Asymmetric Synthesis of AntimalarialAlkaloids (+)-Febrifugine and (+)-Isofebrifugine

Pei-Qiang Huang; Bang-Guo Wei; Yuan-Ping Ruan

doi:10.1055/s-2003-40988

LETTER

Asymmetric Synthesis of AntimalarialAlkaloids (+)-Febrifugine and (+)-Isofebrifugine

Pei-Qiang Huang*, Bang-Guo Wei, Yuan-Ping Ruan
Department of Chemistry, Xiamen University, Xiamen, Fujian 361005,China
Fax: +86(592)2186400; e-Mail: pqhuang@xmu.edu.cn;

Abstract

All articles of this category

Abstract

Diastereoselective α-amidoalkylation of N,O-acetal,derivated from controlled regio and diastereoselective reductionof (S)-N-(4-methoxybenzyl)-3-silyloxyglutarimideprovided two diastereomeric 6-allyl-5-silyloxy-2-piperidinonesin 76:24 selectivity. The transformation of the major diastereomerinto a known advanced intermediate allowed the synthesis of (+)-febrifugineand (+)-isofebrifugine.

Key words

piperidines - alkaloids - allylations - N,O-acetal - asymmetric synthesis

Full Text

References

1

β-Dichroine and α-dichroineare two names once been proposed to two of three isomeric alkaloidsisolated from Dichroa febrifuga Lour.,which were correlated with febrifugine and isofebrifugine respectively,see ref. [2b] [3b]

2a Koepfli JB. Mead JF. Brockman JA. J.Am. Chem. Soc. 1947, 69: 1837

2b Koepfli JB. Mead JF. Brockman JA. J. Am. Chem. Soc. 1949, 71: 1048

2c Murata K. Takeno F. Fushiya S. Oshima Y. J. Nat. Prod. 1998, 61: 729

3a Chou TQ. Jang CS. Fu FY. Kao YS. Huang KC. Science (Chinese) 1947, 29: 49

3b Chou T.-Q. Fu FY. Kao YS. J.Am. Chem. Soc. 1948, 70: 1765

4a Ablondi F. Gordon S. Morton J. Williams JH. J. Org. Chem. 1952, 17: 14

4b Hutchings BL. Gordon S. Ablondi F. Wolf CF. Williams JH. J. Org. Chem. 1952, 17: 19

5a Koepfli JB. Brockman JA. Moffat J. J. Am. Chem. Soc. 1950, 72: 3323

5b Baker BR. McEvoy FJ. Schaub RE. Joseph JP. Williams JH. J. Org. Chem. 1953, 18: 178

5c Takeuchi Y. Azuma K. Abe H. Sasaki K. Harayama T. Chem. Pharm.Bull. 2002, 50: 1011

5d Takeuchi Y. Azuma K. Oshige M. Abe H. Nshioka H. Sasaki K. Harayama T. Tetrahedron 2003, 59: 1639

6a Kobayashi S. Ueno M. Suzuki R. Ishitani H. TetrahedronLett. 1999, 40: 2175

6b Kobayashi S. Ueno M. Suzuki R. Ishitani H. Kim H.-S. Wataya Y. J. Org. Chem. 1999, 64: 6833

7a Jang CS. Fu FY. Wang CY. Huang KC. Lu G. Thou TC. Science 1946, 103: 59

7b Frederick AK. Spencer CF. Folkers K. J. Am. Chem. Soc. 1948, 70: 2091

8a Waletzky E, Berkelhammer G, and Kantor S. inventors; U. S. Patent 3320124.

8b Elkin M. Reich R. Nagler A. Aingorn E. Pines M. De Groot N. Hochberg A. Vlodavsky I. Clin. Cancer Res. 1999, 5: 1982

9 Patnam R. Chang F.-R. Chen C.-Y. Kuo RY. Lee YH. Wu YC. J. Nat. Prod. 2001, 64: 948

10a Takaya Y. Tasaka H. Chiba T. Uwai K. Tanitsu M. Kim H.-S. Wataya Y. Miura M. Takeshita M. Oshima Y. J. Med. Chem. 1999, 42: 3163

10b Kikuchi H. Tasaka H. Hirai S. Takaya Y. Iwabuchi Y. Ooi H. Hatakeyama S. Kim H.-S. Wataya Y. Oshima Y. J. Med.Chem. 2002, 45: 2563

11a Baker BR. Schaub RE. McEvoy FJ. Williams JH. J. Org. Chem. 1952, 17: 132

11b Baker BR. Schaub RE. McEvoy FJ. Williams JH. J.Org. Chem. 1953, 18: 153

11c Baker BR. McEvoy FJ. Schaub RE. Joseph JP. Williams JH. J. Org. Chem. 1953, 18: 178

11d See also: Baker BR. McEvoy FJ. J.Org. Chem. 1955, 20: 118

11e Baker BR. McEvoy FJ. J.Org. Chem. 1955, 20: 136

11f Hill RK. Edwards AG. Chem.Ind. 1962, 858

11g Barringer DF. Beakelhammer GB. Wayne RS. J. Org. Chem. 1973, 38: 1937

11h Burgess LE. Gross EKM. Jurka J. Tetrahedron Lett. 1996, 37: 3255

11i Takeuchi Y. Hattori M. Abe H. Harayama T. Synthesis 1999, 1814

12a Takeuchi Y. Azuma K. Takakura K. Abe H. Harayama T. Chem. Commun. 2000, 1643

12b Okitsu O. Suzuki R. Kobayashi S. Synlett 2000, 989

12c Taniguchi T. Ogasawara K. Org. Lett. 2000, 2: 3193

12d Takeuchi Y. Azuma K. Takakura K. Abe H. Kim H.-S. Wataya Y. Harayama T. Tetrahedron 2001, 57: 1213

12e Ooi H. Urushibara A. Esumi T. Iwabuchi Y. Hatakeyama S. Org.Lett. 2001, 3: 953

12f Sugiura M. Kobayashi S. Org. Lett. 2001, 3: 477

12g Sugiura M. Hagio H. Hirabayashi R. Kobayashi S. Synlett 2001, 1225

12h Okitsu O. Suzuki R. Kobayashi S. J.Org. Chem. 2001, 66: 809

12i Sugiura M. Hagio H. Hirabayashi R. Kobayashi S. J. Am. Chem. Soc. 2001, 123: 12510

13 Huang P.-Q. Liu L.-X. Wei B.-G. Ruan Y.-P. Org. Lett. 2003, 5: 1927

14 Gringore OH. Rouessac FP. In Org. Synth., Coll.Vol. VII Freeman JP. JohnWiley and Sons; New York: 1990. p.99

15a Chamberlin AR. Chung JYL. J. Am. Chem. Soc. 1983, 105: 3653

15b Klaver WJ. Hiemstra H. Speckamp WN. J. Am. Chem. Soc. 1989, 111: 2588

15c Bernardi A. Micheli F. Potenza D. Scolastico C. Villa R. TetrahedronLett. 1990, 31: 4949

16 For a review on clay and clay-supportedreagents in organic synthesis, see: Varma RS. Tetrahedron 2002, 58: 1235

There is not a general rule fordetermining the relative stereochemistry of 5,6-disubstituted 2-piperidinonesby ¹H NMR vicinal coupling constants (J _5,6). However, during the courseof this work, we were able to observed that for N-unsubstituted6-substituted 5-alkoxy- or 5-silyloxy-2-piperidinones, trans-isomers generally show larger J _5,6 (J _5,6>3Hz) than those of cis-isomers (J _5,6<3 Hz). Two literatureprecedents listed below are in support of this argument:

17a Boudreault N. Ball RG. Bayly C. Bermstein MA. Tetrahedron 1994, 50: 7947

17b Bach T. Bergmann H. Brummerhop H. Lewis W. Harms K. Chem.-Eur.J. 2001, 7: 4512

18 Brown DS. Charreau P. Hansson T. Ley SV. Tetrahedron 1991, 47: 1311

19 For a recent review on α-amidoalkylationof N-acyliminium, see: Speckamp WN. Moolenaar MJ. Tetrahedron 2000, 56: 3817

20 Campbell AL. Pilipauqkas DR. Khanna IK. Rhodes RA. TetrahedronLett. 1987, 28: 2331

21 Greene TW. Wuts PGM. ProtectiveGroups in Organic Chemistry 2nd ed.: Wiley; NewYork: 1991. p.401

22a Yamaura M. Suzuki T. Hashimoto H. Yoshimura J. Okamoto T. Shin C. Bull.Chem. Soc. Jpn. 1985, 58: 1413

22b Yoshimura J. Yamaura M. Suzuki T. Hashimoto H. Chem. Lett. 1983, 1001

23

To a cooled (-78 °C)solution of 22 (348 mg, 0.85 mmol) in anhydCH₂Cl₂ (10 mL) was added dropwise allyltrimethyl-silane(0.270 mL, 1.71 mmol). After being stirred for 5 min, a solutionof TiCl₄ (0.14 mL, 1.283 mmol) in anhyd CH₂Cl₂ (2mL) was added over a period of 40 min. The mixture was stirred for4 h at the same temperature and then allowed to warm to r.t. andstirred for 10 h. After which, a sat. aq NaHCO₃ (1 mL)and brine (2 mL) were slowly added. The organic layer was separatedand the aq phase was extracted with CH₂Cl₂ (2 × 2mL). The combined organic layers were dried over anhyd Na₂SO₄ andconcentrated. The crude was purified by chromatography on silicagel (EtOAc/PE) to give pure (5S,6S)-8 (86 mg),pure (5S, 6R)-23 (38 mg), and a mixture of un-separated(5S,6S)-8 and (5S,6R)-23 (191 mg) ina combined yield of 95%. Major diastereomer (5S,6S)-8: colorless oil. [α]_D ²⁰ +56.5(c 1.0, CHCl₃). IR(neat): ν_max = 3075,2952, 2929, 1642,1513, 1463, 1248, 1175 cm^-1. ¹H NMR(500 MHz, CDCl₃): δ = 7.08 (m, 2 H,Ar-H), 6.83 (m, 2 H, Ar-H), 5.87 (m, 1 H, CH=), 5.40 (d, J = 14.6 Hz,1 H, NCH₂), 5.13 (m, 1 H, =CH₂),5.09 (m, 1 H, =CH₂), 3.94-3.88 (m,1 H, H-5), 3.91 (s, 3 H, OCH₃), 3.88 (d, J = 14.6 Hz,1 H, NCH₂), 3.23 (vrt. dt, J = 6.6,4.7 Hz, 1 H, H-6), 2.63 (m, 2 H, =CCH₂) 2.50(ddd, J = 8.0,8.8, 17.0 Hz, 1 H, H-3), 2.27 (ddd, J = 7.4,8.2, 17.0 Hz, 1 H, H-3), 1.94 (m, 1 H, H-4), 1.81 (m, 1 H, H-4),0.9 (s, 9 H, t-Bu), 0.18 (s, 3 H, SiCH₃), 0.08(s, 3 H, Si-CH₃) ppm. ¹³CNMR (125 MHz, CDCl₃): δ = 169.39 (C=O),158.99 (Ar), 136.11 (CH=), 129.44 (Ar), 129.37 (2 C, Ar),117.44 (=CH₂), 114.01 (2 C, Ar), 68.38 (C-6),59.39 (C-5), 55.32 (OCH₃), 48.23 (N-CH₂),33.62 (=CH-CH₂), 28.96 (C-3), 25.77 (C-4), 25.68(3C, t-Bu), 17.97 (SiCMe₃), -4.90(Si-CH₃), -5.13 (SiCH₃) ppm. MS (ESI): m/z (%) = 390(100) [M + H⁺],412 (11) [M + Na⁺].HRMS calcd for [C₂₂H₃₅NO₃Si + H]⁺:390.2464. Found: 390.2463. (5S,6R)-Minor diastereomer 23:colorless oil. [α]_D ²⁰ -51.4(c 1.0, CHCl₃). ¹HNMR (500 MHz, CDCl₃): δ = 7.09 (m,2 H, Ar-H), 6.80 (m, 2 H, Ar-H), 5.67 (m, 1 H, CH=), 5.44(d, J = 14.9Hz, 1 H, NCH₂), 5.12 (m, 1 H, =CH₂),5.09 (m, 1 H, =CH₂), 3.95 (m, 1 H, H-5), 3.78(s, 3 H, OCH₃), 3.77 (d, J = 14.9Hz, 1 H, NCH₂), 3.21 (vrt. ddt, J = 9.8,3.4, 2.0 Hz, 1 H, H-6), 2.70 (ddd, J = 7.2,12.3, 18.5 Hz, 1 H, H-3), 2.52 (m, 1 H, =CCH₂),2.37 (ddd. J = 1.4,6.5, 18.5 Hz, 1 H, H-3), 2.09 (m, 1 H, =CCH₂),2.01 (m, 1 H, H-4), 1.74 (m, 1 H, H-4), 0.8 (s, 9 H, t-Bu), 0.08 (s, 3 H, SiCH₃),0.05 (s, 3 H, SiCH₃) ppm. ¹³CNMR (125 MHz, CDCl₃): δ = 169.68 (C=O),158.79 (Ar), 133.85 (CH=), 129.24 (Ar), 129.20 (2 C, Ar),118.32 (=CH₂), 113.94 (2 C, Ar), 65.78 (C-6),61.86 (C-5), 55.30 (OCH₃), 46.60 (NCH₂), 36.65(=CHCH₂), 26.89 (C-3), 25.68 (3 C, t-BuC), 24.17 (C-4), 17.92 (SiCMe₃), -4.94(2 C, SiCH₃) ppm. MS (ESI): m/z (%) = 390.1(100) [M + H⁺], 412.2(19) [M + Na⁺]. HRMScalcd for [C₂₂H₃₅NO₃Si + H]⁺:390.2464. Found: 390.2463.

24

Major diastereomer (5S,6S)-24: whitesolid. Mp 67-68 °C. [α]_D ²⁰ -4.5(c 1.05, CHCl₃). IR(film): ν_max = 3222,1669 cm^-1. ¹H NMR(500 MHz, CDCl₃): δ = 5.73 (m, 1 H, =CH), 5.61(brs, 1 H, NH), 5.22 (m, 1 H, =CH₂), 5.19 (m,1 H, =CH₂), 4.0 (m, 1 H, H-5), 3.36 (ddd, J = 2.8, 3.6,9.7 Hz, 1 H, H-6, decoupling H-5, J = 3.6,9.7 Hz), 2.57 (ddd, 6.4, 12.1, 18.6 Hz, 1 H, H-3), 2.32 (m, 2 H, =CH-CH₂),2.20 (ddd, J = 9.0,9.8, 18.6 Hz, 1 H, H-3), 1.97 (m, 1 H, H-4), 1.84 (m, 1 H, H-4),0.90 (s, 9 H, t-Bu), 0.08 (s, 3 H, SiCH₃), 0.02(s, 3 H, SiCH₃) ppm. ¹³CNMR (125 MHz, CDCl₃): δ = 171.54 (C=O),133.63 (CH=), 119.54 (CH₂=), 65.96(C-5), 56.43 (C-6), 36.96 (C-4), 28.15 (CH₂-CH=),26.37 (C-3), 25.76 (3 C, t-Bu), 18.11(SiCMe₃), -4.39 (SiCH₃), -4.94 (SiCH₃)ppm. MS (ESI): m/z (%) = 270,(100) [M + H⁺], 292 (20) [M + Na⁺].HR-ESI-MS calcd for [C₁₄H₂₇NO₂Si + H]⁺: 270.1889.Found: 270.1907. Minor diastereomer (5S,6R)-25: whitesolid. Mp 67-68 °C. [α]_D ²⁰ +15.3(c 0.98, CHCl₃). IR(film): ν_max = 3190,1682 cm^-1. ¹H NMR(500 MHz, CDCl₃): δ = 5.74 (m, 1 H,CH=), 5.70 (m, 1 H, NH), 5.21 (dd, J = 0.8, 14.7 Hz, 1 H, =CH₂),5.18 (dd, J = 0.8,14.7 Hz, 1 H, =CH₂), 3.66 (ddd, J = 3.3,6.5, 9.3 Hz, 1 H, H-5, irradiation at H-6 gave dd, J = 3.3,9.3 Hz), 3.23 (ddd, J = 9.5, 6.5, 4.5 Hz,1 H, H-6), 2.53 (ddd, J = 5.8, 6.2, 17.8 Hz,1 H, H-3), 2.34 (ddd, J = 6.5, 9.4, 17.8 Hz,1 H, H-3), 2.12-1.92 (m, 1 H, CH₂CH=),1.84-1.78 (m, 2 H, H-4), 0.9 (s, 9 H, t-Bu),0.56 (s, 3 H, SiCH₃), 0.50 (s, 3 H, SiCH₃)ppm. ¹³C NMR (125 MHz, CDCl₃): δ = 171.28(C=O), 133.41 (CH=), 119.67 (CH₂=),69.11 (C-5), 58.11 (C-6), 38.55 (C-4), 28.46 (C-3), 28.30 (CH₂-CH=),25.71 (3 C, t-Bu), 17.95 (SiCMe₃), -4.27(SiCH₃), -4.75 (SiCH₃) ppm. MS (ESI): m/z (%) = 270(100) [M + H⁺], 292(3) [M + Na⁺]. HR-ESI-MScalcd for [C₁₄H₂₇NO₂Si + H]⁺:270.1889. Found: 270.1890.

25

The ee was determined by HPLC analysisusing a Chiracel^® OJ-H column (0.46 cm × 25cm; column temperature: r.t.; eluent: hexane/isopropylalcohol = 37:3; flow rate = 1.0mL/min; wavelength: 240 and 260 nm, t _R = 11.50and 16.39 min).